Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LP-98 in treatment-naïve HIV-infected adults
CTR20255179Phase 2Active
- Sponsor
- Institute of Pathogen Biology, Chinese Academy of Medical Sciences
- Start
- Jan 2026
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of lipovirtide in human immunodeficiency virus infection (HIV), sponsored by Institute of Pathogen Biology, Chinese Academy of Medical Sciences. Started Jan 2026; status: active.
02
Drugs
lipovirtide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20255179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20255179.